Product Details for ANDA 202552
ACITRETIN (ACITRETIN)
10MG
Marketing Status: Prescription
17.5MG
Marketing Status: Prescription
22.5MG
Marketing Status: Prescription
25MG
Marketing Status: Prescription
10MG
Marketing Status: Prescription
Active Ingredient: ACITRETIN
Proprietary Name: ACITRETIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202552
Product Number: 001
Approval Date: Dec 23, 2015
Applicant Holder Full Name: IMPAX LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
ACITRETIN (ACITRETIN)
Proprietary Name: ACITRETIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202552
Product Number: 001
Approval Date: Dec 23, 2015
Applicant Holder Full Name: IMPAX LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
17.5MG
Marketing Status: Prescription
Active Ingredient: ACITRETIN
Proprietary Name: ACITRETIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 17.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202552
Product Number: 002
Approval Date: Dec 23, 2015
Applicant Holder Full Name: IMPAX LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
ACITRETIN (ACITRETIN)
Proprietary Name: ACITRETIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 17.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202552
Product Number: 002
Approval Date: Dec 23, 2015
Applicant Holder Full Name: IMPAX LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
22.5MG
Marketing Status: Prescription
Active Ingredient: ACITRETIN
Proprietary Name: ACITRETIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 22.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202552
Product Number: 003
Approval Date: Dec 23, 2015
Applicant Holder Full Name: IMPAX LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
ACITRETIN (ACITRETIN)
Proprietary Name: ACITRETIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 22.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202552
Product Number: 003
Approval Date: Dec 23, 2015
Applicant Holder Full Name: IMPAX LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
25MG
Marketing Status: Prescription
Active Ingredient: ACITRETIN
Proprietary Name: ACITRETIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202552
Product Number: 004
Approval Date: Dec 23, 2015
Applicant Holder Full Name: IMPAX LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: ACITRETIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202552
Product Number: 004
Approval Date: Dec 23, 2015
Applicant Holder Full Name: IMPAX LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information